<html>
<head>PUBMED IDs for CREF</head>
<body bgcolor='#C5F0F2'><h1>CREF</h1><a href='https://pubmed.ncbi.nlm.nih.gov/6091106/'>Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products.</a> September 1  1984<br><a href='https://pubmed.ncbi.nlm.nih.gov/6492253/'>Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen.</a> November 1  1984<br><a href='https://pubmed.ncbi.nlm.nih.gov/3877564/'>Regulation of anchorage-independent growth by thyroid hormone in type 5 adenovirus-transformed rat embryo cells.</a> December 1  1985<br><a href='https://pubmed.ncbi.nlm.nih.gov/2938185/'>Mutations in the E1a gene of adenovirus type 5 alter the tumorigenic properties of transformed cloned rat embryo fibroblast cells.</a> April 1  1986<br><a href='https://pubmed.ncbi.nlm.nih.gov/3017738/'>Cleavage of vimentin in dense cell cultures. Inhibition upon transformation by type 5 adenovirus.</a> September 1  1986<br><a href='https://pubmed.ncbi.nlm.nih.gov/3019001/'>Characterization of Fischer rat embryo (CREF) cells transformed by bovine papillomavirus type 1.</a> October 15  1986<br><a href='https://pubmed.ncbi.nlm.nih.gov/2972843/'>Regulation of adenovirus and cellular gene expression and of cellular transformation by the E1B-encoded 175-amino-acid protein.</a> December 1  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/2195986/'>Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).</a> May 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/2141089/'>The efficiency of adenovirus transformation of rodent cells is inversely related to the rate of viral E1A gene expression.</a> July 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/2146803/'>Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis.</a> December 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/2060183/'>The influence of the presence of adenovirus 5 E1a and E1b sequences on the pathology of rat embryonic fibroblasts transfected with activated c-Ha-ras and v-ras.</a> May 1  1991<br><a href='https://pubmed.ncbi.nlm.nih.gov/1580547/'>Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.</a> March 1  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/8385576/'>Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.</a> April 15  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8302156/'>Glial cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter.</a> November 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8189528/'>Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats.</a> June 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/21559551/'>Expression of the transformed phenotype induced by diverse acting viral oncogenes mediates sensitivity to growth suppression induced by caffeic Acid phenethyl ester (cape).</a> July 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7542776/'>Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.</a> July 18  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8572584/'>Phospholipases A2 in ras-transfected fibroblasts.</a> September 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8572568/'>Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells.</a> September 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9143284/'>Spontaneous occurrence of early region 1A reiteration mutants of type 5 adenovirus in persistently infected human T-lymphocytes.</a> April 14  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9465091/'>Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10618724/'>Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.</a> January 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11087688/'>Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional yapsin 1 (Yps1p) endoprotease.</a> November 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11380461/'>Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis.</a> May 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12115734/'>Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells.</a> July 13  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516560/'>Analysis of expressed V(H) genes in persistent polyclonal B cell lymphocytosis reveals absence of selection in CD27+IgM+IgD+ memory B cells.</a> January 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15465000/'>Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, fumarylacetoacetate hydrolase.</a> October 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15638932/'>A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay.</a> January 11  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17854500/'>Molecular evolution of type VI intermediate filament proteins.</a> September 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19940250/'>Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis.</a> February 13  2009<br></body></html>
